Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dose Tapering and Early Discontinuation to InCreAse cosT-effectIveness Of Immunotherapy for Non-small Cell Lung Carcinoma

NCT04909684 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT04909684
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04909684 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dose Tapering and Early Discontinuation to InCreAse cosT-effectIveness Of Immunotherapy for Non-small Cell Lung Carcinoma
Lead sponsor
Radboud University Medical Center
Phase
Phase 3
Overall status
Unknown status
Start date
November 18, 2020
Completion date
November 30, 2024
Enrollment
750 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nsclc